Labcorp Perspectives: Oncology | Innovations in oncology: Highlights from ASCO's annual meeting (Episode 3)

The latest episode of Labcorp Perspectives: Oncology featuring Dr. Rebecca Previs, director of medical affairs at Labcorp Oncology, and Dr. Eric Severson, executive director of medical affairs at Labcorp, share notable insights from the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. They explore the role of liquid biopsies in cancer diagnostics, specifically Labcorp's Plasma Complete™ test, a noninvasive alternative to traditional biopsies. The discussion also covers the use of machine learning to predict microsatellite instability (MSI) in solid tumors and research on overcoming immune resistance in triple-negative breast cancer (TNBC).